Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab
Authors:
Bullement A, D’Angelo SP, Amin A, Stapelkamp C, Willis A, Lilley C, Hatswell A and Bharmal M.
Publication type:
Journal article
Publication name:
Journal of Clinical Oncology
Citation:
Bullement A, D’Angelo SP, Amin A, Stapelkamp C, Willis A, Lilley C, Hatswell A and Bharmal M. Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab. J Clin Oncol. 2018; 36(15_suppl):e21620-e.
